TRU-SENTIMENT · DeltaNeutral
NBIX Trading Analysis - 09/24/2026 01:48 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
NBIX (Neurocrine Biosciences Inc) at $138.57. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $1,230 vs put $0. RSI 16.3.
- Symbol
- NBIX
- Price
- $138.57
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-24 13:48:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Options sentiment is bullish, with:
- Call dollar volume: $1230
- Put dollar volume: $0
- Call %: 100%
The pure directional positioning suggests near-term bullish expectations.
Key Statistics: NBIX
Fundamental Snapshot
Valuation
| P/E (Trailing) | 20.45 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 7.81 |
Profitability
| EPS (Trailing) | $6.82 |
| EPS (Forward) | N/A |
| ROE | 19.10% |
| Net Margin | 20.91% |
Financial Health
| Revenue (TTM) | $3.37B |
| Debt/Equity | 0.45 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for NBIX include:
- Neurocrine Biosciences (NBIX) announced positive topline results from their Phase 3 trial for Crinecerfont in congenital adrenal hyperplasia (CAH).
- The company reported strong quarterly earnings, beating analyst expectations and driving stock price increases.
- NBIX received FDA approval for their new treatment, expanding their portfolio and potential revenue streams.
These headlines suggest a positive outlook for NBIX, with potential catalysts for future growth. The technical and sentiment data should be analyzed in the context of these recent developments.
Fundamental Analysis:
Based on the provided fundamentals:
- Revenue: $3,373,900,000
- Trailing EPS: $6.82
- Trailing P/E: 20.45
- Debt/Equity: 0.45
- ROE: 19.10%
The company's fundamentals indicate a strong revenue base, healthy profitability, and a reasonable valuation. However, the lack of forward EPS and revenue growth rate makes it difficult to assess future prospects.
Current Market Position:
Current price: $138.64
Recent price action shows a decline in the stock price, with the current price near the lower end of the 30-day range ($137 - $160.43).
Technical Analysis:
Technical Indicators
SMA trends:
- 5-day SMA: $142.11
- 20-day SMA: $151.74
- 50-day SMA: $159.62
The stock is currently below all three SMAs, indicating a downtrend. RSI is oversold (< 30), and MACD shows a bearish signal.
True Sentiment Analysis (Delta 40-60 Options):
Options sentiment is bullish, with:
- Call dollar volume: $1230
- Put dollar volume: $0
- Call %: 100%
The pure directional positioning suggests near-term bullish expectations.
Key Price Levels:
Support and resistance levels based on recent price action and indicators.
25-Day Price Forecast:
NBIX is projected for $136.00 to $140.00
Based on current trends, momentum, and indicators, the stock price may fluctuate within this range over the next 25 days.
Defined Risk Strategy Recommendations:
Based on the price forecast:
- Buy Bull Call Spread: NBIX 261016C00135000 (strike $135.0) and sell NBIX 261016C00140000 (strike $140.0)
- Sell Bear Put Spread: NBIX 261016P00135000 (strike $135.0) and buy NBIX 261016P00140000 (strike $140.0)
- Iron Condor: Sell NBIX 261016C00130000 (strike $130.0) and buy NBIX 261016C00125000 (strike $125.0), sell NBIX 261016P00140000 (strike $140.0) and buy NBIX 261016P00145000 (strike $145.0)
Risk Factors:
- Technical weaknesses: oversold RSI, bearish MACD
- Sentiment divergences: bullish options flow vs bearish technicals
- Volatility: ATR 4.13
Summary & Conviction Level:
Overall bias: Neutral
Conviction level: Medium
One-line trade idea: Options flow suggests bullish near-term expectations, but technicals show bearish signals.
View NBIX Options Chain